227 related articles for article (PubMed ID: 19124396)
21. Lipid management in children.
Zappalla FR; Gidding SS
Endocrinol Metab Clin North Am; 2009 Mar; 38(1):171-83. PubMed ID: 19217518
[TBL] [Abstract][Full Text] [Related]
22. Cardiometabolic abnormalities in current National Football League players.
Selden MA; Helzberg JH; Waeckerle JF; Browne JE; Brewer JH; Monaco ME; Tang F; O'Keefe JH
Am J Cardiol; 2009 Apr; 103(7):969-71. PubMed ID: 19327424
[TBL] [Abstract][Full Text] [Related]
23. The metabolic syndrome as an endocrine disease: is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis?
Schindler C
Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):7-26. PubMed ID: 19124392
[TBL] [Abstract][Full Text] [Related]
24. The current unmet need in type 2 diabetes mellitus: addressing glycemia and cardiovascular disease.
Levy P
Postgrad Med; 2009 May; 121(3 Suppl 1):7-12. PubMed ID: 19494472
[TBL] [Abstract][Full Text] [Related]
25. Treatment of hypertension and other cardiovascular risk factors in patients with metabolic syndrome.
Suzuki T; Homma S
Med Clin North Am; 2007 Nov; 91(6):1211-23, x. PubMed ID: 17964917
[TBL] [Abstract][Full Text] [Related]
26. Early pharmacological intervention in newly diagnosed metabolic syndrome and type 2 diabetes.
Naruszewicz M
Przegl Lek; 2006; 63 Suppl 4():7-8. PubMed ID: 16967707
[No Abstract] [Full Text] [Related]
27. The dilemma of the metabolic syndrome in children and adolescents: disease or distraction?
Jones KL
Pediatr Diabetes; 2006 Dec; 7(6):311-21. PubMed ID: 17212598
[TBL] [Abstract][Full Text] [Related]
28. The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting.
Neira CP; Hartig M; Cowan PA; Velasquez-Mieyer PA
J Am Acad Nurse Pract; 2009 Mar; 21(3):173-8. PubMed ID: 19302694
[TBL] [Abstract][Full Text] [Related]
29. The metabolic syndrome and schizophrenia.
Meyer JM; Stahl SM
Acta Psychiatr Scand; 2009 Jan; 119(1):4-14. PubMed ID: 19133915
[TBL] [Abstract][Full Text] [Related]
30. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
Chapman MJ; Sposito AC
Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
[TBL] [Abstract][Full Text] [Related]
32. Onset of puberty and cardiovascular risk factors in untreated obese children and adolescents: a 1-year follow-up study.
Reinehr T; Toschke AM
Arch Pediatr Adolesc Med; 2009 Aug; 163(8):709-15. PubMed ID: 19652102
[TBL] [Abstract][Full Text] [Related]
33. Tracking of cardiometabolic risk factor clustering from childhood to adulthood.
Camhi SM; Katzmarzyk PT
Int J Pediatr Obes; 2010 Apr; 5(2):122-9. PubMed ID: 19593726
[TBL] [Abstract][Full Text] [Related]
34. Management of metabolic syndrome in young population.
Brandão AP; Brandão AA; de Magalhães ME; Pozzan R
Am J Ther; 2008; 15(4):356-61. PubMed ID: 18645340
[TBL] [Abstract][Full Text] [Related]
35. Update in prevention of atherosclerotic heart disease: management of major cardiovascular risk factors.
Romero-Corral A; Somers VK; Korinek J; Sierra-Johnson J; Thomas RJ; Allison TG; Lopez-Jimenez F
Rev Invest Clin; 2006; 58(3):237-44. PubMed ID: 16958300
[TBL] [Abstract][Full Text] [Related]
36. Evaluating obesity and cardiovascular risk factors in children and adolescents.
Spiotta RT; Luma GB
Am Fam Physician; 2008 Nov; 78(9):1052-8. PubMed ID: 19007051
[TBL] [Abstract][Full Text] [Related]
37. Survey of cardiovascular risk factors in overweight and obese patients (SCOOP study) six-month changes in risk factor levels and cardiovascular risk.
Iori I; Fatati G; Fusco MA; Leonardi F; Matthieu G; Scanelli G; Lanti M; Menotti A
Eur J Intern Med; 2009 May; 20(3):280-8. PubMed ID: 19393495
[TBL] [Abstract][Full Text] [Related]
38. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).
Graham I; Atar D; Borch-Johnsen K; Boysen G; Burell G; Cifkova R; Dallongeville J; De Backer G; Ebrahim S; Gjelsvik B; Herrmann-Lingen C; Hoes A; Humphries S; Knapton M; Perk J; Priori SG; Pyorala K; Reiner Z; Ruilope L; Sans-Menendez S; Op Reimer WS; Weissberg P; Wood D; Yarnell J; Zamorano JL; Walma E; Fitzgerald T; Cooney MT; Dudina A; Vahanian A; Camm J; De Caterina R; Dean V; Dickstein K; Funck-Brentano C; Filippatos G; Hellemans I; Kristensen SD; McGregor K; Sechtem U; Silber S; Tendera M; Widimsky P; Zamorano JL; Altiner A; Bonora E; Durrington PN; Fagard R; Giampaoli S; Hemingway H; Hakansson J; Kjeldsen SE; Larsen ML; Mancia G; Manolis AJ; Orth-Gomer K; Pedersen T; Rayner M; Ryden L; Sammut M; Schneiderman N; Stalenhoef AF; Tokgözoglu L; Wiklund O; Zampelas A; ; ; ; ; ; ; ; ; ;
Eur J Cardiovasc Prev Rehabil; 2007 Sep; 14 Suppl 2():E1-40. PubMed ID: 17726406
[No Abstract] [Full Text] [Related]
39. Obesity and shift work: chronobiological aspects.
Antunes LC; Levandovski R; Dantas G; Caumo W; Hidalgo MP
Nutr Res Rev; 2010 Jun; 23(1):155-68. PubMed ID: 20122305
[TBL] [Abstract][Full Text] [Related]
40. Potential role of new therapies in modifying cardiovascular risk in overweight patients with metabolic risk factors.
Jensen MD
Obesity (Silver Spring); 2006 Jun; 14 Suppl 3():143S-149S. PubMed ID: 16931496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
